Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Comera Life Sciences Inc...

    NASDAQ: CMRAW · Real-Time Price · USD
    0.02
    null (null%)
    At close: Sep 17, 2024, 8:00 PM

    Comera Life Sciences Statistics

    Share Statistics

    Comera Life Sciences has 318.55K shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 318.55K

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.71 and the forward PE ratio is null. Comera Life Sciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.71

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 20.31

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -2.06

    P/FCF Ratio

    n/a
    		 -1.31

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Comera Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.61, with a Debt / Equity ratio of -0.12.

    Current Ratio

    n/a
    		 0.61

    Quick Ratio

    n/a
    		 0.61

    Debt / Equity

    n/a
    		 -0.12

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 -587.02

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $52,758.5

    Profits Per Employee

    n/a
    		 $-1,500,341.5

    Employee Count

    n/a
    		 12

    Asset Turnover

    n/a
    		 0.17

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -20.43, so Comera Life Sciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -20.43

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.01

    200-Day Moving Average

    n/a
    		 0.03

    Relative Strength Index (RSI)

    n/a
    		 43.66

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, Comera Life Sciences had revenue of 633.1K and earned -18M in profits. Earnings per share was -1.76.

    Revenue

    n/a
    		 633.1K

    Gross Profit

    n/a
    		 422.71K

    Operating Income

    n/a
    		 -11.97M

    Net Income

    n/a
    		 -18M

    EBITDA

    n/a
    		 -17.89M

    EBIT

    n/a
    		 -17.98M

    Earnings Per Share (EPS)

    n/a
    		 -1.76
    Full Income Statement

    Balance Sheet

    The company has 446.61K in cash and 775.05K in debt, giving a net cash position of -328.44K.

    Cash & Cash Equivalents

    n/a
    		 446.61K

    Total Debt

    n/a
    		 775.05K

    Net Cash

    n/a
    		 -328.44K

    Retained Earnings

    n/a
    		 -34.9M

    Total Assets

    n/a
    		 3.07M

    Working Capital

    n/a
    		 -301.92K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.77M and capital expenditures -28.61K, giving a free cash flow of -9.8M.

    Operating Cash Flow

    n/a
    		 -9.77M

    Capital Expenditures

    n/a
    		 -28.61K

    Free Cash Flow

    n/a
    		 -9.8M

    FCF Per Share

    n/a
    		 -0.94
    Full Cash Flow Statement

    Margins

    Gross margin is 66.77%, with operating and profit margins of -1890.69% and -2843.79%.

    Gross Margin

    n/a
    		 66.77%

    Operating Margin

    n/a
    		 -1890.69%

    Pretax Margin

    n/a
    		 -2843.79%

    Profit Margin

    n/a
    		 -2843.79%

    EBITDA Margin

    n/a
    		 -2825.23%

    EBIT Margin

    n/a
    		 -1890.69%

    FCF Margin

    n/a
    		 -1547.99%

    Dividends & Yields

    CMRAW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CMRAW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -28.11

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist